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1 Introduction
The group B streptococcus (GBS, Streptococcus 
agalactiae) has been one of the leading causes of 
neonatal infections in the western world since the 
early 1970s [3, 5, 81. The incidence of GBS dis- 
ease varies over different countries, but appears 
to be constant over the last fifteen years [6]. GBS 
infections can have an early or a late onset, each 
of which is associated with a distinct clinical pic­
ture.
Early-onset disease (EOD) occurs in the first 
seven days of life and is usually caused by verti­
cal transmission from the birth canal. Of all preg­
nant women, 4—40% are colonized with GBS, 
depending on the population, the sample sites and 
culture methods [4, 6, 9, 12]. The rectum is the 
main reservoir, which often contaminates the va­
gina [9, 11]. Transmission during labor occurs in 
28—73%, but only 1 — 5% of colonized infants 
develop EOD [2, 12]. The incidence amounts to 
0.7-3.7/1000 live births [6]. Low birth weight, 
preterm delivery, prolonged rupture of mem­
branes, signs of intrapartum infection, heavy col­
onization and multiple birth have been noted to 
be risk factors for EOD [3, 8], Infants of mothers 
with low levels of serogroup-specific antibodies 
against GBS also have a higher risk to develop 
disease [6]. The most common manifestation of 
EOD is respiratoiy disease, which may resemble 
the clinical picture of hyaline membrane disease 
[14]. Other manifestations are sepsis, meningitis, 
jaundice and lethargy, but the infection may be 
asymptomatic as well [5]. The prognosis of EOD
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seems to have improved over the years: older 
studies report mortality rates of 50—80%, while 
rates of 13—37% are reported more recently [6].
Late-onset disease (LOD) occurs after seven days 
of age and is caused by both vertical transmission 
and nosocomial contact [3, 6]. The incidence of 
LOD amounts to 0.8—1.9/1000 live births [3, 6]. 
LOD more often presents as meningitis (85%) 
and sepsis, as well as local infections, including 
osteoarthritis, urinary tract infection, pneumonia 
and cellulitis [6, 14]. LOD has a mortality rate 
of 0—23% [3, 14], Unfortunately, approximately 
50% of GBS-meningitis survivors will develop 
neurological damage [7].
©  1996 by Walter de Gruyter & Co. Berlin • New York
532
In this study, all patients with neonatal GBS in­
fection admitted to the neonatal intensive care 
unit of our hospital between 1985 and 1993 were 
reviewed to verify the tendency of decreasing 
mortality described by others, as well as to estab­
lish the long-term outcome in relation to prognos­
tic and fisk factors.
2 Material and methods
The data of all patients with a GBS-positive 
blood or cerebrospinal fluid culture, as well as 
patients with clinical symptoms and either posi­
tive superficial (ear, nose, throat, umbilicus) or 
maternal cervical culture were rewiewed.
Maternal fever >  38 °C, leucocytosis (> 1 6  
X 109/liter) and/or fetal tachycardia of > 160  
beats per minute were regarded as intrapartum 
signs of infection. Gestational age, duration of 
membrane rupture, birth weight, sex, 5 minute 
Apgar score, clinical and laboratory findings, 
treatment and clinical outcome at the age of at 
least one year were recorded. To determine out­
come, data from the latest visit to the out-patient 
clinic were used or a questionnaire was sent to 
the parents,
3 Results
3.1 Frequency and mortality
EOD was diagnosed in 78 patients (41 males, 37 
females). In 61, there were both symptoms and a 
positive blood culture. A positive blood culture 
without symptoms was found in 14 patients. 
Three patients had no positive blood culture but 
clear symptoms; two of them were treated with 
antibiotics before culturing. In 8 of the 78 pa­
tients other microorganisms were cultured from 
blood as well: Escherichia coli (3), Staphylococ­
cus aureus (3), viridans streptococci (1) and 
Klebsiella pneumoniae plus Proteus mirabilis (1). 
All these eight patients had symptoms of infec­
tious disease. All five patients in whom cerebro­
spinal fluid cultures were GBS-positive died.
In figure 1 the distribution of cases and mortality 
over the years is shown. The number of newborns 
with EOD varied from 4 to 14 per year. Overall 
mortality rate was found to be 23%.
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LOD occurred in four patients (2 males, 2 fe­
males). Two patients, both with meningitis, died 
and the other two survived without sequelae. 
They were not further included into this study
3.2 Clinical presentation
Fourteen patients with EOD (18%) had a positive 
blood culture without clinical symptoms. In all 
remaining 64 cases of EOD, manifestations oc­
curred within the first 48 hours. These were a 
variety of combinations of respiratory disease 
(53%), persistent pulmonary hypertension (16%), 
shock (13%), convulsions (12%), hyperbilirubin­
emia (9%), signs of necrotizing enterocolitis 
(8%), apnoea and bradycardia (5%), hypotonia 
(5%), cyanosis (3%) and oedema (3%). Labora­
tory findings consisted of leucocytosis, thrombo- 
penia, leucopenia, hyperglycemia, metabolic aci­
dosis and elevated C~reactive protein,
3.3 Treatment
Treatment consisted of intravenous administra­
tion of a ß-lactam antibiotic (ampicillin, amoxi­
cillin or a third generation cephalosporin) in com­
bination with an aminoglycoside (mostly genta- 
micin). In some cases, patients were treated with 
a penicillin-derivative only, including amoxicil- 
iin/clavulanic acid. In a number of cases, admin­
istration of antibiotics was changed from intrave­
nous into oral after a few days.
3*4 Risk factors
The presence of risk factors and related mortality 
were reviewed in all patients with EOD (table I). 
Half of the patients had a gestational age below 
37 weeks. Of all fatal cases, 61% was below 37 
weeks. Remarkably, no mortality was found in the 
group between 34-37 weeks. Thirty-two patients 
(41%) had a birth weight below 2500 g, and 35% 
of them died. GBS-infection was not related to 
fetal growth retardation, since the population 
showed a normal distribution over the birth 
weight percentiles (figure 2) [10], Thirty-eight 
patients had a birth weight below and 40 above 
the 50th percentile.
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Figure 1. Number o f  neonates per year with GBS early onset disease (EOD) and related mortality.
Table I. Most important risk factors* in 78 cases o f neonatal GBS early onset disease and related mortality
Parameter GBS
early onset disease 
(%)
Mortality
(%)
Gestational age 2 6 - 2 8  weeks 8 (10) 5(28)
28—34 weeks 20 (26) 6(33)
3 4 - 3 7  weeks 12(15) 0
^ 3 7  weeks 38 (49) 7(39)
Duration o f  ruptured membranes 0— 12 hours 16 (20) 7(39)
12—24 hours 16 (20) 6 (33)
24—48 hours 21 (27) 0
5*48 hours 18(23) 4(22)
unknown 7 (9) I (6)
Intrapartum signs o f  infection** absent 46 (59) 6(33)
present 29 (37) 12(67)
unknown 3 (4) 0
Number o f  risk factors* present 0 13 (17) 4(22)
I 24 (30) 8(44)
2 16(21) 0
3 15(19) 4(22)
unknown 10(13) 2 ( 12)
* Most important known risk factors from the literature: preterm delivery ( < 3 7  weeks), prolonged rupture o f  
membranes ( > 2 4  hours before delivery), and intrapartum maternal fever.
** Maternal temperature >  38 °C, , and/or maternal leucocytosis >  16 X 109/1, and/or fetal tachycardia >  160 
beats/min.
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Figure 2. Number of neonates with GBS early onset disease (EOD) and related mortality by birth weight percentile 
[10].
Prolonged rupture of membranes (>  24 hours) 
was present in at least 50% of all cases; duration 
was unknown in 9%. Signs of intrapartum infec­
tion were present in over one third of all cases
(37%).
Data about risk factors were incomplete in 10 pa­
tients; however, 5 of them had at least one risk 
factor Therefore, at least one risk factor was pre­
sent in 82% of the cases (60/73). This leaves 
about one out of fi ve patients without any of the 
three risk factors studied,
3.5 Follow-up
In 44 of the 60 survivors (73%) long term follow 
up data of at least one year were available, Four­
teen parents did not return the questionnaire, two 
families had moved and could not be located. 
Thirty of these 44 patients (68%) had no se­
quelae. Unfortunately, one of them suffered from 
Hemophilus influenzae meningoencephalitis at 
the age of 10 months, which left him severely 
handicapped. Three patients suffered from spastic 
tetraplegia, one of them also showed mental retar­
dation. Two patients had a combination of spastic 
diplegia and congenital strabismus. Logopedia
was indicated for three patients, one of them 
never had symptoms of GBS-sepsis. Neuromotor 
developmental delay was present in four patients, 
one of them also had problems with speech and 
social development. One patient had behavioral 
problems and EEG disturbances and one had ab­
sences at a very young age.
Table II shows the outcome in the 78 patients 
with EOD. Mortality was higher in neonates with 
lower gestational age (< 3 4  weeks: 39% vs ^  34 
weeks: 14%) with more sequelae among the sur­
vivors with known outcome (44% vs 25%), In 
neonates with a gestational age of ^  37 weeks, 
the mortality rate was 19% and sequelae were 
found in 24% of survivors with known outcome. 
Of the 32 patients born within 24 hours after the 
membranes had ruptured 13 died (41%), and 6 of 
the 13 patients with known outcome had sequelae 
(46%). Thirty-nine patients were bom after pro­
longed rupture of membranes, 4 (10%) died, and 
7 of 27 patients with known outcome (26%) had 
sequelae. The presence of intrapartum signs of in­
fection did not increase the mortality rate, but 
doubled the frequency of sequelae in survivors 
with known outcome (47% vs 23%). Survivors 
with known outcome, born by caesarean section,
J. Perinat. Med. 24 (1996)
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had more sequelae (58%) than those born by in­
strumental or spontaneous delivery (27%). 
Among neonates with a 5 minute Apgar score 
<  7 the mortality rate was higher (31 %) than in 
the group with a score 7 (21%). Two thirds of 
survivors in the low Apgar score group had se­
quelae versus 23% in the high Apgar score group. 
Eleven of 26 surviving patients (42%) with symp­
toms of GBS-infection within one hour after birth
had sequelae. Nine of them were severely dam­
aged. Two of five surviving patients with symp­
toms between one and six hours after birth had 
(minor) sequelae. Among the four surviving pa­
tients with symptoms occurring after six hours 
and known outcome, no sequelae were found. 
Early treatment, within one hour after birth, re­
sulted in less mortality, but did not influence the 
outcome in survivors. All patients with spastic
Table IL Presence of some parameters and related outcome of 78 neonates with GBS early onset disease
Parameter N Mortality
0
Permanent sequelae 
in survivors
unknown
(%)
no
(%)
yes
(%)
Gestational age <28 weeks 8 5(62) 2 67) 1(33)
2 8 -3 4  weeks 20 6(30) 1 (7) 7 50) 6(43)
34—37 weeks 12 — 5(42) 5 42) 2(16)
5:37 weeks 38 7(19) 10(32) 16 52) 5(16)
Duration of ruptured <24 hours 32 13(41) 6(32) 7 36) 6(32)
membranes 5*24 hours 39 4(10) 8(23) 20 57) 7(20)
unknown 7 1(14) 2(33) 3 50) 1(17)
Intrapartum signs of absent 46 12 (26) 8(24) 20 59) 6(17)
infection* present 29 6 (21) 8(35) 8 35) 7(30)
unknown 3 -- - 2 67) 1 (33)
Mode of delivery spontaneous 47 ] 3 (28) 8(24) 19 56) 7(20)
instrumental 10 - 4(40) 6 60) —
c. section 21 5(24) 4(25) 5 31) 7(44)
5 min. Apgar score <  7 13 4(31) — 3 33) 6(67)
^  7 65 14(21) 16(31) 27 53) 8(16)
Onset of symptoms** <  1 h postpartum 45 11 (24) 8(24) 15 44) 11 (32)
1 — 6 h postpartum 7 2(29) — 3 60) 2(40)
6 — 12 h postpartum 2 1(50) — 1 ( 00) —
12—24 h postpartum 7 3(43) 2(50) 2 50)
24—48 h postpartum 3 1(33) 1 (50) 1 50)
Start of treatment <  1 h postpartum 34 1 (3) 9(27) 15 46) 9(27)
1 -  6 h postpartum 9 6(67) -- 2 67) 1 (33)
6 —12 h postpartum 15 5(33) 1 (10) 6 60) 3 (30)
12—24 li postpartum 5 3(60) 1(50) I 50) —
24-48  h postpartum 10 3(30) 3(43) 3 43) 1(14)
5*48 h postpartum 5 -- 2(40) 3 60) -
* Maternal temperature ^  38 °C, and/or maternal leucocytosis >  16 X i09/l, and/or fetal tachycardia >160 beats/ 
min.
** 14 neonates with GBS-positive blood culture did not develop clinical symptoms as early treatment was started 
because of signs of infection in the mother and/or laboratory findings.
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disorders were preterm. Three of four patients 
with neuromotor developmental delay were over 
37 weeks of gestational age. All eight patients 
with positive cultures of other microorganisms 
besides GBS survived.
4 Discussion
To reduce adverse outcome of early onset GBS- 
disease, early identification and treatment is 
essential. We could not prove any decrease in 
mortality rate of infants with EOD during the last 
ten years in our population. Prematurity, pro­
longed rupture of membranes and antenatal signs 
of infection were confirmed as risk factors. Birth 
weight was not found to be an independent risk 
factor, but reflected gestational age, Absence of 
risk factors does not ecxlude EOD, since almost 
20% of patients had none of the studied risk 
factors. In all cases of neonatal disease of un­
known origin, GBS-sepsis should be included in 
the differential diagnosis.
As 14 patients were treated because of GBS-posi- 
tive blood culture before any symptoms devel­
oped, their inclusion in the study can be debated. 
The possibility of contamination of blood cultures 
collected from a peripheral vene, and especially 
from umbilical vessels or catheters, cannot be to­
tally excluded [13]. If they would not have devel­
oped EOD without treatment, their inclusion
would be incorrect. Then, the prognosis of EOD 
in this study would be worse.
The outcome in the group of neonates born after 
prolonged rupture of membranes was not unfa­
vorable, probably due to a higher degree of alert­
ness to GBS-disease. Patients born by ceasarean 
section had more sequelae, which can probably 
be explained by fetal distress being the reason for 
emergency caesarean section.
It is difficult to predict outcome of GBS-sepsis 
in individual cases. Sequelae cannot always be 
exclusively related to GBS-sepsis, especially in 
preterm infants. Outcome is also determined by 
the occurrence of other disorders such as cerebral 
hemorrhage and periventricular leucomalacia. 
Prematurity and sepsis are both risk factors for 
intraventricular hemorrhage and periventricular 
leucomalacia, while maternal GBS colonization 
has been associated with preterm birth [1], In our 
population, all patients with spastic disorders had 
intraventricular hemorrhage or periventricular 
leucomalacia, and ail were premature.
In conclusion, outcome of GBS-sepsis is influ­
enced by many factors, including gestational age, 
onset of symptoms and time of treatment, sever­
ity of respiratory and circulatory disease and the 
occurrence of complications related to prematu­
rity. Alertness to the presence of GBS disease is 
mandatory for early treatment and good outcome.
Abstract
Retrospectively, morbidity and mortality of neonatal 
early onset group B streptococcal (GBS) infection were 
established. Risk factors and prognostic factors were de­
termined. Between 1985 and 1993, 78 patients with 
early onset GBS disease were identified. The overall 
mortality rate was 23%. In 60 of 73 cases (82%) at least 
one of the investigated risk factors was. present. Low 
birth weight was not an independent risk factor. Out­
come of 44 o f  60 survivors (73%) at the age of at least 
one year was obtained. Almost 30% of them had se­
quelae. The most important were spastic disorders and 
delayed psychomotor development. In 42% of patients
with symptoms of GBS-infection within six hours after 
birth sequelae occurred. There were no sequelae among 
patients with symptoms after 6 hours. All 9 severely 
brain damaged infants showed symptoms shortly after 
birth. Mortality and adverse outcome rate were higher in 
infants with low gestational age or low 5 minute Apgar 
scores. Early treatment resulted in less mortality, but not 
in less sequelae.
GBS-sepsis still causes significant mortality and leaves 
a substantial number o f  survivors damaged. Alertness 
to GBS-infection, even in the absence of risk factors, 
remains crucial for early treatment and good outcome.
Keywords: Neonatal intensive care units, neonatal mortality, newborn, prognosis, risk factors, septicemia, Strep­
tococcus agalactiae.
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Zusammenfassung
Früh einsetzende neonatale Infektion mit Strepto­
kokken der Gruppe B. Eine retrospektive Studie 
über neun Jahre in einer Universitäts-Klinik
W ir berichten retrospektiv über alle Fälle von bewiese­
ner GBS-Sepsis, die in der Zeit zwischen 1985 und 
1993 auf der neonatalen Intensivstation des Universi­
tà fs-Krankenhauses aufgetreten sind. Die Studie wurde 
durchgeführt, um die Morbidität und Mortalität von 
neonataler früh einsetzender Infektion mit Streptokok­
ken der Gruppe B (GBS) festzustellen. Außerdem wur­
den sowohl Risikofaktoren wie prognostische Faktoren 
ermittelt. Wir erwarben Patientendaten nach mindestens 
einem Jahr aus den medizinischen Berichten oder via 
eines Fragebogens, den wir den Eltern schickten.
E s wurden achtundsiebzig Patienten mit früh einsetzen­
der GBS-Erkrankung identifiziert. Die totale Mortalität 
betrug 23%. Alle 5 Patienten (6,5%), die die Symptome 
einer Meningitis zeigten, starben. In 60 der 73 Fälle 
(82%) war mindestens einer der untersuchten Risiko­
faktoren (Frühgeburtlichkeit, Zeichen  von Infektion 
während der Entbindung und länger zurückliegender 
Blasensprung) vorhanden (Table 1). Niedriges Geburts­
gewicht war kein unabhängiger Risikofaktor (Fig. 2).
Wir erhielten Patientendaten von 44 der 60 Überleben­
den (73%) (Table II). Fast 30% von ihnen hatte Folge­
symptome. Die wichtigsten davon waren spastische 
Leiden und eine verzögerte psychomotorische Entwick­
lung. Bei 42% der Patienten mit Symptomen der GBS- 
Infektion innerhalb von 6 Stunden nach der Geburt tra­
ten Folgesymptome auf. Es wurden keine Folgesymp­
tome in der Patientengruppe, bei der die Infektionssym­
ptome nach einem Intervall von mehr als 6 Stunden 
nach der Geburt auftraten, festgestellt. Alle 9 Neugebo­
renen mit schwerer Gehirn Schädigung zeigten die Sym­
ptome kurz nach der Geburt. Mortalität und die Rate 
der ungünstigen KrankheitsVerläufe waren höher bei 
Frühgeborenen und Kindern, die einen niedrigen (<  7) 
Apgar-Score nach 5 Minuten hatten. Frühe Behandlung 
resultierte in niedrigerer Mortalität, reduzierte jedoch 
nicht die Folgesymptome. GBS-Sepsis verursacht noch 
immer eine signifikante Mortalität und hinteriäßt eine
*4 _
erhebliche Anzahl von Überlebenden mit Schäden. 
Wachsamkeit in Bezug auf GBS-Infektion, selbst wenn 
Risikofaktoren nicht vorhanden sind, bleibt entschei­
dend für eine frühe Behandlung und bessere Resultate.
Schlüsselwörter: Neonatale Intensivstation, neonatale Mortalität, Neugeborene, Prognose, Risikofaktoren, Sepsis,
Streptococcus agalactiae,
Résumé
Infections néonatales précoces à stréptocoque du 
groupe B. Une étude rétrospective sur neuf ans dans 
un centre hospitalier universitair
On a passé en revue rétrospectivement tous les cas 
prouvés de septicémie à stréptocoque du groupe B 
(GBS) précoce dans une unité de soins intensifs néona­
tals entre 1985 et 1993 pour déterminer la morbidité et 
mortalité. En outre, nous avons évalué les facteurs de 
risque de même que les facteurs prognostiques. Les 
données supplémentaires ont été obtenues par des dos­
siers médicaux ou par une questionnaire rempli par les 
parents.
Soixante-dix-huit patients souffrants de GBS précoce 
ont été identifié. Le taux de mortalité total était de 23%. 
Tous les 5 patients (6,5%) souffrants de méningite sont 
morts. En 60 cas sur 73 (82%) au moins un des facteurs 
de risque examinés à été présent: prématurité, des 
symptômes d’infection pendant la grossesse et une rup­
ture prolongée des membranes (tableau I). Le faible 
poids à la naissance n ’était pas un facteur de risque in­
dépendant (fig. 2), Nous avons obtenu des données sup­
plémentaires sur 44 des 60 survivants (73%) après au 
moins un an (tableau II). A peu près 30% d ’entre-eux 
souffrait de suites; les plus importantes étaient des spas- 
ticités et développement psychomoteur retardé. Dans 
42% des patients qui montraient des symptômes d’in­
fection GBS dans les premiers 6 heures après la nais­
sance, se sont présentés des suites. Il n ’y avait pas de 
suites parmi les patients ou se sont présentés des 
symptômes après 6 heures. Tous les 9 enfants avec en­
dommagement cérébral sévère montraient des symptô­
mes peu après la naissance. La mortalité et le taux des 
séquels étaient supérieurs parmi les enfants nés préma­
turément ou avec un score d ’Apgar à 5 minutes moins 
de 7. Le traitement prompt a fait baisser la mortalité, 
mais n'a pas réduit les séquels.
La septicémie GBS provoque toujours une mortalité si­
gnificative. En même temps, parmi les survivants un 
nombre substantiel reste endommagé.
Il est crucial de rester vigilant à l’infection GBS pour 
assurer le traitement prompt et pour avoir des bons ré­
sultats.
Mots-clés: Facteurs de risque, mortalité néonatale, nouveau-né, prognostic, septicémie, Streptococcus agalactiae,
unité de soins intensifs néonatals.
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